[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 7090 Introduced in House (IH)]
<DOC>
118th CONGRESS
2d Session
H. R. 7090
To amend the Internal Revenue Code of 1986 to exclude from gross income
certain compensation to clinical trial participants.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
January 25, 2024
Mr. Kelly of Pennsylvania (for himself and Ms. Houlahan) introduced the
following bill; which was referred to the Committee on Ways and Means
_______________________________________________________________________
A BILL
To amend the Internal Revenue Code of 1986 to exclude from gross income
certain compensation to clinical trial participants.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. EXCLUSION OF COMPENSATION PROVIDED TO PARTICIPANTS IN
CLINICAL TRIALS.
(a) In General.--Part III of subchapter B of chapter 1 of the
Internal Revenue Code of 1986 is amended by inserting after section
139I the following new section:
``SEC. 139J. CLINICAL TRIAL PAYMENTS.
``(a) In General.--Gross income shall not include any amount
received by an individual as payment or reimbursement for participation
in an approved clinical trial (including amounts paid or reimbursed for
meals, lodging, or other travel expenses incurred in connection with
such participation).
``(b) Approved Clinical Trial.--The term `approved clinical trial'
has the meaning given such term in section 2709(d)(1) of the Public
Health Service Act (42 U.S.C. 300gg-8(d)(1)).''.
(b) Clerical Amendment.--The table of sections for part III of
subchapter B of chapter 1 of such Code is amended by inserting after
the item relating to section 139I the following new item:
``Sec. 139J. Clinical trial payments.''.
(c) Effective Date.--The amendment made by this section shall apply
to amounts paid after December 31, 2023.
<all>